• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-胡萝卜素对某些抗肿瘤药致突变活性的影响。

Effect of beta-carotene on mutagenic activity of some antineoplastics.

作者信息

Belisario A, Panza N, Pacilio G

出版信息

Acta Vitaminol Enzymol. 1985;7 Suppl:75-8.

PMID:3916048
Abstract

Mutagenic activity on Salmonella typhimurium strains of some cytostatic drugs in the absence and in the presence of beta-carotene was evaluated. Cyclophosphamide mutagenicity was reduced by the retinoid both in vitro and in vivo. Conversely, its metabolite 4'-hydroxy-cyclophosphamide, which does not require enzymatic transformation to exert genotoxic activity against bacteria, was not affected by the presence of beta-carotene. Moreover, the mutagenic activity of cis-Platinum, Adriamycin and 4'Epiadriamycin, which are typical direct-acting mutagens, was not affected by beta-carotene. Data obtained confirm that beta-carotene is able to prevent mutagenic activity of cyclophosphamide by interfering with its metabolic activation but failed to inhibit the interaction of genotoxic compounds with bacterial DNA.

摘要

评估了某些细胞抑制药物在不存在和存在β-胡萝卜素的情况下对鼠伤寒沙门氏菌菌株的致突变活性。在体外和体内,类视黄醇均降低了环磷酰胺的致突变性。相反,其代谢物4'-羟基环磷酰胺(对细菌发挥基因毒性活性不需要酶促转化)不受β-胡萝卜素存在的影响。此外,顺铂、阿霉素和4'-表阿霉素(典型的直接作用诱变剂)的致突变活性也不受β-胡萝卜素的影响。获得的数据证实,β-胡萝卜素能够通过干扰环磷酰胺的代谢活化来预防其致突变活性,但未能抑制基因毒性化合物与细菌DNA的相互作用。

相似文献

1
Effect of beta-carotene on mutagenic activity of some antineoplastics.β-胡萝卜素对某些抗肿瘤药致突变活性的影响。
Acta Vitaminol Enzymol. 1985;7 Suppl:75-8.
2
Inhibition of cyclophosphamide mutagenicity by beta-carotene.β-胡萝卜素对环磷酰胺致突变性的抑制作用。
Biomed Pharmacother. 1985;39(8):445-8.
3
Mutagenicity of cancer chemotherapeutic agents in the Salmonella/microsome test.
Cancer Res. 1977 Jul;37(7 Pt 1):2209-13.
4
Limitations of urinary mutagen assays for monitoring occupational exposure to antineoplastic drugs.
Am J Hosp Pharm. 1986 Feb;43(2):344-8.
5
Monitoring of effects of cis-diamminedichloroplatinum II (Platidiam). Part II. Tests for mutagenic activity in the indicator system of Salmonella typhimurium his- strains (Ames test).顺二氯二氨铂(铂得定)的效果监测。第二部分。鼠伤寒沙门氏菌组氨酸缺陷型菌株指示系统中的致突变活性测试(艾姆斯试验)
Neoplasma. 1985;32(3):307-12.
6
Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.细胞色素P - 450诱导剂对大鼠体内环磷酰胺致突变性和致畸性的影响
Teratology. 1981 Aug;24(1):1-11. doi: 10.1002/tera.1420240102.
7
Structure-activity relationship of anthracycline-induced genotoxicity in vitro.蒽环类药物体外诱导遗传毒性的构效关系
Cancer Res. 1984 Dec;44(12 Pt 1):5599-604.
8
[The role of UDP glucuronosyl- and sulfotransferases in the butylhydroxytoluene suppression of the mutagenic action of carcinogenic nitroso compounds and cyclophosphane].[尿苷二磷酸葡萄糖醛酸基转移酶和磺基转移酶在丁基羟基甲苯抑制致癌亚硝基化合物和环磷酰胺诱变作用中的作用]
Vopr Onkol. 1989;35(2):220-5.
9
Study on the mutagenicity and antimutagenicity of beta-ionone in the Salmonella/microsome assay.β-紫罗兰酮在沙门氏菌/微粒体试验中的致突变性和抗突变性研究。
Food Chem Toxicol. 2006 Apr;44(4):522-7. doi: 10.1016/j.fct.2005.08.026. Epub 2005 Oct 11.
10
Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.沙门氏菌/人源S9致突变性试验:58种化合物的协作研究
Mutagenesis. 2005 May;20(3):217-28. doi: 10.1093/mutage/gei029. Epub 2005 Apr 20.